Abstract
Nanocardiology is the application of nanobiotechnology to cardiovascular diseases. Recent rapid advances in nanobiotechnology offer a wealth of new opportunities for diagnosis and therapy of cardiovascular diseases (Jain 2011a). As far back as 2003, the National Heart, Lung, and Blood Institute, USA, convened a working group on nanotechnology for translational applications to heart, lung, blood disorders, and cardiovascular complications of sleep apnea to solve clinical problems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ashammakhi N, Wimpenny I, Nikkola L, Yang Y. Electrospinning: methods and development of biodegradable nanofibres for drug release. J Biomed Nanotechnol 2009;5:1–19.
Banai S, Chorny M, Gertz SD, et al. Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials 2005;26:451–61.
Brito L, Amiji M. Nanoparticulate carriers for the treatment of coronary restenosis. Int J Nanomedicine 2007;2:143–61
Chan JM, Zhang L, Tongc R, et al. Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc Natl Acad Sci U S A 2010;107:2213–8.
Chen HH, Josephson L, Sosnovik DE. Imaging of apoptosis in the heart with nanoparticle technology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3:86–99.
Chnari E, Nikitczuk JS, Uhrich KE, et al. Nanoscale Anionic Macromolecules Can Inhibit Cellular Uptake of Differentially Oxidized LDL. Biomacromolecules 2006;7:597–603.
Davis ME, Hsieh PC, Takahashi T, et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A 2006;103:8155–60.
Feng SS, Zeng W, Teng Lim Y, et al. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment. Nanomed 2007;2:333–44.
Floriano PN, Christodoulides N, Miller CS, et al. Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem 2009;55:1530–8.
Guarise C, Pasquato L, De Filippis V, Scrimin P. Gold nanoparticles-based protease assay. Proc Natl Acad Sci U S A 2006;103:3978–82.
Hsieh PCH, Davis ME, Gannon J, et al. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 2006;116:237–48.
Jain KK. Handbook of Biomarkers. Springer, New York, 2010.
Jain KK. Applications of Biotechnology in Cardiovascular Therapeutics. Springer, New York, 2011a.
Kumar A, Jena PK, Behera S, et al. Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine 2010;6:64–9.
Lanza GM, Winter PM, Caruthers SD, et al. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. Nanomedicine 2006;1:321–9.
Leite EA, Grabe-Guimarães A, Guimarães HN, et al. Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices. Life Sci 2007;80:1327–34.
Margolis J, McDonald J, Heuser R, et al. Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study. Clin Cardiol 2007;30:165–70.
Saraste A, Nekolla SG, Schwaiger M. Cardiovascular molecular imaging: an overview. Cardiovasc Res 2009;83:643–52.
Uwatoku T, Shimokawa H, Abe K, et al. Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats. Circ Res 2003;92:e62–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jain, K.K. (2012). Nanocardiology. In: The Handbook of Nanomedicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-983-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-61779-983-9_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-982-2
Online ISBN: 978-1-61779-983-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)